Sapu Nano’s Sapu003 Advances to Human Clinical Testing - Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients

Sapu Nano, developer of Deciparticle™, today announced that it has received approval from Australia’s Human Research Ethics Committee (HREC) ...
TipRanks on MSN

Philogen Reports Strong Revenue Growth and Advances in Clinical Pipeline

An announcement from Philogen SpA ( ($IT:PHIL) ) is now available. Philogen S.p.A. reported its half-year financial results for 2025, showing a ...

Biotechnology for the Non-Biotechnologist | 5-Day Online Training Course (Nov 10th-14th, 2025) with 18 CPD Hours | Explore Key Techniques and Regulatory Advances in the Biotech ...

The biotech industry is poised for growth, driven by advancements in biomedical science and innovation. Opportunities include development of new drugs, focus on biosimilars and advanced therapies, and ...

Novel label-free biosensing platform advances monoclonal antibody biomanufacturing

A research team at the Terasaki Institute, led by Dr. Vadim Jucaud in collaboration with Dr. Jing Yong Ye from the University ...
PharmiWeb

Kinea Bio Secures $1.1M Jain Foundation Investment and Solid Biosciences Capsid License to Advance Novel Gene Therapy for Dysferlinopathy, a Rare Neuromuscular Disease

Non-exclusive license for Solid Biosciences’ proprietary, next-generation myotropic capsid, AAV-SLB101, to accelerate development of KNA-155 for dysferlinopathySEATTLE--(BUSINESS WIRE)--Kinea Bio Inc.